Pre-operative administration of butorphanol mitigates emergence agitation in patients undergoing functional endoscopic sinus surgery: A randomized controlled clinical trial
Frontiers in Psychiatry · 17.01.2023 · 13
DOI: 10.3389/fpsyt.2022.1090149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 17.01.2023. Verfasst von Xiao Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
This study explored the effectiveness of pre-operative intravenous injection of butorphanol in the alleviation of emergence agitation (EA) in patients undergoing functional endoscopic sinus surgery (FESS).
Methods
Patients ( n = 708) were randomized into two groups. The butorphanol group (Group B, n = 358) received butorphanol infusion (20 ug/kg) before anesthesia induction, while the control group (Group C, n = 350) received an equal volume of normal saline infusion. General anesthesia was induced with sufentanil, propofol, and rocuronium, and was maintained with sevoflurane and remifentanil. Vasoactive drugs maintained the hemodynamic indices within 20% of the baseline.
Results
The incidence of EA was significantly lower in Group B than that in Group C (Group B vs. C: 24.3% vs. 31.4%, respectively; P = 0.034). The times to spontaneous breathing (26.5 min vs. 23.7 min, P = 0.011), verbal response (36.0 min vs. 33.4 min, P = 0.012), and extubation (31.0 min vs. 28.7 min, P = 0.025) were longer in Group B, and the grade of cough (0.33 vs. 0.43, P = 0.024) at extubation in Group B was lower than that in Group C ( P = 0.024). The mean arterial pressure at the end of the operation ( P = 0.004) and at 5 min after extubation ( P = 0.008) was higher and hypotension was less prominent (0.6% vs. 2.6%, P = 0.030) in Group B.
Conclusion
Pre-operative intravenous injection of butorphanol decreased the incidence of EA after FESS and provided smooth and hemodynamically stable emergence without extending the stay in post-anesthesia care unit. Clinical trial registration https://www.clinicaltrials.gov/ , identifier NCT03398759.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of Anesthesiology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, X., Qi, S., Lin, Z., Zhang, Y., Dai, W., Tian, W., Tian, J., Zheng, L., Su, D., & Huai, X. (2023). Pre-operative administration of butorphanol mitigates emergence agitation in patients undergoing functional endoscopic sinus surgery: A randomized controlled clinical trial. Frontiers in Psychiatry, 13. https://doi.org/10.3389/fpsyt.2022.1090149
Vancouver
Zhang X, Qi S, Lin Z, Zhang Y, Dai W, Tian W, et al. Pre-operative administration of butorphanol mitigates emergence agitation in patients undergoing functional endoscopic sinus surgery: A randomized controlled clinical trial. Frontiers in Psychiatry. 2023;13. doi:10.3389/fpsyt.2022.1090149
BibTeX
@article{Zhang2023,
author = {Zhang, Xiao and Qi, Siyi and Lin, Zhen and Zhang, Yizhe and Dai, Wanbing and Tian, Weitian and Tian, Jie and Zheng, Li and Su, Diansan and Huai, Xiaorong},
title = {Pre-operative administration of butorphanol mitigates emergence agitation in patients undergoing functional endoscopic sinus surgery: A randomized controlled clinical trial},
journal = {Frontiers in Psychiatry},
year = {2023},
volume = {13},
doi = {10.3389/fpsyt.2022.1090149}
}
EUVIMED